Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial

Watchlist | Portfolio | Dashboard

Alexion Pharm Inc (ALXN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] by (Cboe BZX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]

Balance Sheet for [[ item.sessionDateDisplayLong ]]

Fiscal Year End Date: 12/31

(Values in U.S. thousands)

	09-2008	06-2008	03-2008	12-2007	09-2007
Assets
Current Assets
Cash & Cash Equivalents	124,150	106,101	104,854	95,321	91,500
Marketable Securities	1,700	1,696	1,693	10,433	20,413
Receivables	70,715	56,138	53,702	46,278	31,625
Inventories	49,724	48,048	33,085	32,907	32,212
TOTAL	$270,420	$228,130	$218,125	$204,417	$190,702

Non-Current Assets
PPE Net	128,450	119,387	111,219	104,280	92,964
Intangibles	29,946	30,194	30,443	20,891	19,954
Other Non-Current Assets	1,527	1,478	4,207	4,769	17,485
TOTAL	$159,923	$151,059	$145,869	$129,940	$130,403

Total Assets	$430,343	$379,189	$363,994	$334,357	$321,105

Liabilities
Current Liabilities
Short Term Debt	7,000	4,500	N/A	N/A	N/A
Accounts payable and accrued liabilities	9,890	6,989	6,080	9,072	10,547
Accrued Expenses	41,809	35,819	28,695	28,324	22,454
TOTAL	$61,387	$54,636	$58,435	$37,709	$33,286

Non-Current Liabilities
Long Term Debt	N/A	2,500	2,500	N/A	N/A
Deferred Revenues	2,398	2,044	880	41	18
aiOther Non-Current Liabilities	194,916	194,900	194,593	194,593	194,624
TOTAL	$195,196	$197,755	$197,520	$195,092	$195,194

Total Liabilities	$256,583	$252,391	$255,955	$232,801	$228,480

Shareholders' Equity
Shares Outstanding, K	155,852	155,598	153,674	152,427	150,369
Common Shares	8	4	4	4	4
Retained earnings	-711,466	-731,154	-733,528	-729,279	-716,947
Other shareholders' equity	4,707	-1,860	-1,971	-1,703	-1,201
TOTAL	$173,760	$126,798	$108,039	$101,556	$92,625

Total Liabilities And Equity	$430,343	$379,189	$363,994	$334,357	$321,105